REFERENCES

References

Alarco, AM., Balan, I., Talibi, D., Mainville, N., and Raymond, M. 1997. AP1-mediated multidrug resistance in Saccharomyces cerevisiae requires FLR1 encoding a transporter of the major facilitator superfamily. J. BioI. Chem. 272: 19304-19313.

Alarco, AM., and Raymond, M. 1999. The blip transcription factor Cap1p is involved in multidrug resistance and oxidative stress response in Candida albicans. J. Bacteriol. 181: 700-708.

Allen, D.M. and Ang, B.S. 1992. The prevalence of invasive candidiasis in patients with extensive burns. Ann. Acad. Med. Singapore 21: 656-659.

Alonso, A, Martinez, E., Struzinsky, R, Michaljanicova, D., and Kotyk, A 1983. Interaction of Nystatin with Nystatin-resistant Candida tropicalis. Folia Microbiol. 28: 157-162.

Ananthanarayanan, R, and Paniker, C.K.J. 1978. Textbook of Microbiology.

Andrade, AC., Del Sorbo, G., Van Nisterlooy, J.G.M., and De Waard, M.A 2000a. The ABC transporter AtrB from Aspergillus nidulans mediates resistance to all major classes of fungicides and some natural toxic compounds. Microbiology 146: 1987-1997.

Andrade, AC., Van Nistelrooy, J.G.M., Peery, J.G.M., Skatrud, P.L., and De Waard, M.A 2000b. The role of ABC transporters from Aspergillus nidulans in protection against cytotoxic agents and in antibiotic production. Mol. Gen. Genet. 263: 966-977.

Angermayr, K., Parson, W., Stoffler, G., and Haas, H. 1999. Expression of atrC-encoding a novel member of the ATP binding cassette transporter family in Aspergillus nidulans -is sensitive to cycloheximide. Biochem. Biophys. Acta 1453: 304-310.

Aoki, S., Ito-Kuwo, S., Nakamura, Y., and Masuhara, T. 1990. Comparative pathogenicity of a wild-type strain and respiratory mutants of Candida albicans in mice. lentralbl Bakteriol. 273: 332-343.

Aoyama, Y., Yoshida, Y., Hata, S., Nishino, T., Katsuki, H., Maitra, U.S., Mohan, V.P., and Sprinson, D.B. 1983. Altered cytochrome P-450 in a yeast mutant blocked in demethylating C-32 of lanosterol. J. BioI. Chem. 258: 9040-9042.

Arie, l.R, Altboum, l., Sandovsky-Losica, H., and Segal, E. 1998. Adhesion of Candida albicans mutant strains to host tissue. FEMS Microbiol. Lett. 163: 121-127.

Baily, G.G., Moore, C.B., Essayag, S.M., Wit, S. de, Burnie, J.P. and Denning, D.W. 1997. Candida inconspicua, a fluconazole-resistant pathogen in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 25: 161-163.

134

References

Baker, J.H., Goodpasture, H.C., Kuhns, H.RJr., and Rinaldi, M.G. 1989. Fungemia caused by an amphotericin B-resistant isolate of Sporothrix schenckii. Successful treatment with itraconazole. Arch. Pathol. Lab. Med. 113: 1279-1281.

Balan, I., Alarco, AM., and Raymond, M. 1997. The Candida albicans CDR3 gene codes for an opaque-phase ABC transporter. J. Bacteriol. 179: 7210-7218.

Ballard, S.A, Kelly, S.L., Ellis, S.W. and Troke, P.F. 1990. Interaction of microsomal cytochrome P-450 isolated from Aspergillus fumigatus with Fluconazole and Itraconazole. J. Med. Vet. Mycol. 28: 327-34.

Banerjee, D, Pillai, B , Karnani, N, Mukhopadhyay, G and Prasad, R Genome-wide expression profile of steroid response in Saccharomyces cerevisiae. Biochem. Biophy. Res. Comm., 317: 406-413.

Barchiesi, F., Hollis, RJ., McGough, D.A, Scalise, G., Rinaldi, M.G. and Pfaller, M.A 1995a. DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patient~ with AIDS. Clin. Infect. Dis. 20: 634-40.

Barchiesi, F., Hollis, RJ., Del Poeta M., McGough, D.A, Scalise, G., Rinaldi, M.G. and Pfaller, M.A 1995b. Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field gel electrophoresis. Clin. Infect. Dis. 21: 561-4.

Barchiesi, F., Calabrese, D., Sanglard, D., Francesco, L.F., Caselli, F., Giannini, D., Giacometti, A, Gavaudan, S., and Scalise, G. 2000. Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob. Agents Chemother. 44: 1578-1584.

Barnert, J., Behr, W., and Reich, H. 1985. An amphotericin B-resistant case of rhinocerebral mucor mycosis. Infection. 13: 134-136.

Barnett, J.A, Payne, R.W. and Yarrow, D. 2000. Yeasts: Characteristics and identification, 3rd ed. Cambridge University Press, Cambridge, United Kingdom.

Baron, JOE, Peterson, L.R and Finegold, M.S., Editors. Bailey and Scott's Diagnostic Microbiology. 9th edn. St. Louis: CV Mosby, 1994: 274-8.

Barrett-Bee, K. and Dixon, G. 1995. Ergosterol biosynthesis inhibition: a target for antifungal agents. Acta Biochem Polonica 42: 465-480.

Bart-Delabesse, Van Deventer, E., H., Goessens, W., Poirot, J.-L., Lioret, N., Van Belkum, A and F. Dromer. 1995. Contribution of molecular typing methods and antifungal susceptibility testing to the study of a Candidemia cluster in a burn care unit. J. Clin. Microbiol. 33:3278-3283.

135

References

Beck-Sague, C.M., Jarvis, W.R, and the National Nosocomial Surveillance System.1993.Secular trends in the epidemology of nosocomial fungal infections in the United States.1980-1990. J.lnfect.Dis. 167: 1247-1251.

Ben-Yaacov, R, Knoller, S., Caldwell, G.A., Becker, J.M., and Koltin, Y. 1994. Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob. Agents Chemother. 38: 648-652.

Blash, J.L. 2002. Systemic Candida infections in patients with leukemia: an overview of drug therapy. Clin. J. Oncol. Nurs. 6: 323-331.

Bossche, HV., Willemsens G., and Marichal P. 1987. Anti-Candida drugs- the biochemical basis for their activity. Crit Rev Microbio/15: 57-72.

Bossche, HV., Marichal, P., and Odds, F.C. 1994. Molecular mechanisms of drug resistance in fungi. Trends Microbio/, 2: 393-400.

Buckley, H.R 1989. Identification of yeasts- In Book on Medical Mycology-a practical approach. Oxford University Press.

Calabrese, D. C., Bille, J., and Sanglard, D. 1999. Characterization of FLU1, a novel multidrug efflux transporter gene from C. albicans. ASM conference on Candida and Candidiasis. C56.

Calabrese, D., Bille, J., and Sanglard, D. 2000. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. Microbiology 146: 2743-2754.

Cameron, M.L., Schell, W.A., Bruch, S., Bartlett, J.A., Waskin, H.A. and Perfect, J.R (1993). Correlation of invitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 37: 2449-2453.

Cartwright, RW. 1976, A simple technique for observing germ tube formation in Candida albicans. J. Clin. Pathol. 29: 267-268.

Chakrabarti, A., Nayak, N., Kumar, P.S., Talwar, P., Chari, P.S. and Panigrahi, D. 1992. Surveillance of nosocomial fungal infections in a burn care unit. Infection 20: 132-135.

Coleman, D.C., Bennett, D.E., Sullivan, D.J., Gallagher, P.J., Henman, M.C., Shanley, D.B. and Russell, RJ. 1993. Oral Candida in HIV infection and AIDS: new perspectives! new approaches. Crit. Rev. Microbiol. 19: 61-82.

Coleman, D.C., Rinaldi, M.G., Haynes, K.A., Rex, J.H., Summerbell, RC., Anaissie, E., Li, A., and Sullivan, D.J. 1998. Importance of Candida species other than Candida albicans as opportunistic pathogens. Med. Mycol. 36:156-165.

136

References

Corrado, M.L., Weitzman, I., Stanek, A, Goetz, R., and Agyare, E. 1980. Subcutaneous infection with Phialophora richardsiae and its susceptibility to 5-fluorocytosine, amphotericin Band miconazole. Sabouraudia 18: 97-104.

Cruz, M.C., Goldstein, AL., Blankenship, J.R., Poeta, M.D., Davis, D., Cardenas, M.E., Perfect, J.R., McCusker, J.H., and Heitman, J. 2002. Calcineurin is essential for survival during membrane stress in Candida albicans. EMBO J. 21: 546-559.

Cuenca-Estrella, M., Diaz-Guerra, T.M., Mellado, E., and Rodriguez-Tudela, J.L. 2001. Flucytosine primary resistance in Candida species and Crytococcus neoformans. Eur. J. Clin. Microbiol. Infect. Dis. 20: 276-279.

Cui, Z., Shiraki, T., Hirata, D., and Miyakawa, T. 1998. Yeast gene YRR1, which is required for resistance to 4-nitroquinoline N-oxide, mediates transcriptional activation of the multidrug resistance transporter gene SNQ2. Mol. Microbiol. 29: 1307-1315.

Dean, D.A and Burchard, K.W. 1998. Surgical perspective on invasive Candida infections. World J. Surg. 22: 127-134.

de Bedout, C., Gomez, B.L., and Restrepo, A 1997. In vitro susceptibility testing of Fonsecaea pedrosoito antifungals. Rev. Inst. Med. Trop. Sao Paulo 39: 145-148.

Decottignies, A, Lambert, L., Catty, P., Degand, H., Epping, E.A, Moye-Rowley, W.S., Balzi, E. and Goffeau, A 1995. Identification and characterization of SNQ2, a new multidrug ATP binding cassette transporter of the yeast plasma membrane. J. BioI. Chem. 270: 18150-18157.

Debono, M. and Gordee, R.S. 1994. Antibiotics that inhibit fungal cell wall development. Ann Rev Microbiol. 48: 471-497.

De Hoog, G.S. and Guarra. 1995. Atlas of Clinical Fungi. Centraalbureau voor Schimmelcultures, Barn and Delft, the Netherlands, and Universitat Rovira i Virgili, Resus, Spain.

Del Sorbo, G., Andrade, AC., Van Nisterlooy, J.G., Van Kan, J.A, Balzi, E., and De Waard, M.A 1997. Multidrug resistance in Aspergillus nidulans involves novel ATP-binding cassette transporters. Mol. Gen. Genet. 254: 417-426.

Diaz-Guerra, T.M., Mellado, E., Cuenca-Estrella, M., and Rodriguez-Tudela, J.L. 2003. A point mutation in the 14alpha-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus. Antimicrob. Agents Chemother. 47: 1120-1124.

Dogra, S., Krishnamurthy, S., Gupta, V., Dixit, B.L., Gupta, C.M., Sanglard, D., and Prasad, R. 1999. Asymmetric distribution of phosphatidylethanolamine in Candida albicans: possible mediation by CDR1, a multidrug transporter belonging to ATP binding cassette (ABC) superfamily. Yeast 15: 111-121.

137

References

Domon MH, Mathieu LG and de Repentigny J. Changes in the activity of antifungals in mixed cultures of bacteria and yeasts. Can J Microbiol. 1981; 27: 843-6.

Dromer, F., Improvisi, L., Dupont, B., Eliaszewicz, M., Pialoux, G., Fournier, S. and Feuillie, V. 1997. Oral transmission of Candida albicans between partners in HIV-infected couples could contribute to dissemination of fluconazole-resistant isolates. AIDS. 11: 1095-101.

Dutta, S., and Narang, A 2003. Drug-resistant neonatal Candida tropicalis septicemia. Did it cause diaphragmatic hernia? Indian Pediatr. 40: 261-264.

Espinell-Ingroff, A, Barchiesi, F., Hazen, K.C., Martinez-Suarez, J.V. and Scalise, G. 1998. Standardization of antifungal susceptibility testing and clinical relevance. Medical Mycology. 36: 68-78.

Favel, A, Michel-Nguyen, A, Peyron, F., Martin, C., Thomachot, L., Datry, L., Bouchara, J.P., Challier, S., Noel, T., Chastin, C., and Regli, P. 2003. Colony morphology switching of Candida lusitaniae and acquisition of multidrug resistance during treatment of a renal infection in a newborn: case report and review of literature. Diag. Microbiol. Infect. Dis. 47: 331-339.

Fierro F. and Martin J.F. 1999. Molecular mechanisms of chromosomal rearrangement in fungi. Crit Rev Microbio/25: 1-17.

Fischer-Hoch, S.P. and Hutwagner, L 1995. Opportunistic candidiasis: an epidemic of the 1980s. Clin. Infect. Dis. 21: 897-904.

Fling, M.E., Kopf, J., Tamarkin, A, Gorman, J.A, Smith, H.A, and Koltin, Y. 1991. Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol. Gen. Genet. 227: 318-329.

Fonzi, W.A and Irwin, M.Y. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 4: 717-728.

Franz, R., Kelly, S.L., Lamb, D.C., Kelly, D.E., Ruhnke, M. and Morschhauser, J. 1998 a. Multiple molecular mechanisms contribute to a stepwise development of Fluconazole resistance in clinical Candida albicans strains. Antimicrob. Agents Chemother. 42: 3065-3072.

Franz R., Michel S., and Morschhauser J. 1998 b. A fourth gene from the Candida albicans CDR family of ABC transporters. Gene 220: 91-98.

Fraser, J.A, Davis, M.A, and Ynes, M.J. 2002. A gene from Aspergillus nidulans with similarity to URE2 of Saccharomyces cerevisiae encodes a glutathione S-transferase which contributes to heavy metal and xenobiotic resistance. Appl. Environ. Microbiol. 68: 2802-2808.

138

References

Freydiere, A.M., Guinet, R. and Boiron, P. 2001; Yeast identification in the clinical microbiology laboratory: phenotypical methods. Med. Mycol. 39: 9-33.

Fridkin, S.A. and Jarvis, W.R. 1996. Epidemiology of nosocomial fungal infections. Clin. Microbiol. Rev. 9: 499-511.

Georgopapadakou, N.H. and Walsh, T.J. 1996. Antifungal agents: chemotherapeutic targets and immunologic strategies. Antimicrob Agents Chemother 40: 279-291.

Ghannoum, M., and Rice, L.B. 1999. Antifungal agents: Mode of action, mechanism of resistance, and correlation of these mechanisms with bacterial resistance. Clin. Microbiol. Rev. 12: 501-512.

Goff, D.A., Koletar, S.L., Buesching, W.J., Barnishan, J., Fass, R.J. 1995. Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles. Clin. Infect. Dis. 20: 77-83.

Gomez, B.L., and Nosanchuk, J.D. 2003. Melanin and fungi. Curro Opin. Infect. Dis. 16: 91-96.

Gottlieb, G.S, Limaye, A.P., Chen, Y.C. and Van Vooris, W.C. 2001. Candida dublieniensis fungemia in a solid organ transplant patient: case report and review of the literature. Med. Mycol. 39: 483-485.

Green, D., Still, J.M. Jr. and Law, E.J. 1994. Candida parapsilosis sepsis in patients with burns: report of six cases. J. Burn Care Rehabil. 15: 240-243.

Grillot R, Portmann-Coffin V and Ambroise-Thomas P. Growth inhibition of pathogenic yeasts by Pseudomonas aeruginosa in vitro: clinical implications in blood cultures. Mycoses 1994; 37: 343-7.

Guan, J., Braks, H.M.J., Kerkenaar, A., and De Waard M.A. 1992. Interaction of microsomal cytochrome P-450 isozymes isolated from Penicillium italicum with DM1 fungicides. Pest. Biochem. Physiol. 42: 24-34.

Gupta, V., Kohli, A.K., Krishnamurthy, S., Puri, N., Aalamgeer, S.A., Panwar, S.L., and Prasad, R. 1998. Identification of mutant alleles of CaMDR1, a major facilitator of Candida albicans which confers multidrug resistance and its in vitro transcriptional activation. Curr. Genet. 34: 192-199.

Haase, E., Servos, J., Brendel, M. 1992. Isolation and characterization of additional genes influencing resistance to various mutagens in the yeast Saccharomyces cerevisiae. Curr. Genet. 21: 319-324.

Harry, J.B., Song, J.L., Lyons, C.N. and White, T.C. 2002. Transcription initiation of genes associated with azole resistance in Candida albicans. Medical Mycology 40: 73-81.

139

References

Hazen, K.C. 1995. New and emerging yeast pathogens. Clin. Microbiol. Rev. 8: 462-478.

Heggers, J.P., Robson, M.C., Ko, F., Cook, J. and Landa, S.J. 1982. Transient and resident microflora of burn unit personnel and its influence on burn wound sepsis. Infect. Control 3: 471-474.

Hellauer, K., Akache, B., MacPherson, S., Sirard, E., and Turcotte, B. 2002. Zinc cluster protein Rdr1 p is a transcriptional repressor of the PDR5 gene encoding a multidrug transporter. J. BioI. Chem. 277: 17671-17676.

Hikkel, I., Lucas, C., Delaveau, T., Marc, P., Devaux, F., and Jacq, C. 2003. A general strategy to uncover transcription factor properties identifies a new regulator of drug resistance in yeast. J. BioI. Chem. 278: 11427-11432.

Hitchcock, C.A., Pye, G.W., Troke, P.F., Johnson, E.M., and Warnock, D.W. 1993. Fluconazole resistance in Candida glabrata. Antimicrob. Agents Chemother. 37: 1962-1965.

Hoegl, L., Thoma-Geber, E., Rocken, M. and Korting, H.C. 1998. Persistent of oral candidosis by non-albicans Candida strains including Candida glabrata in human immunodeficiency virus-infected patient observed over a period of 6 years. Mycoses 41: 335-338.

Hogan DA and Kolter R. Pseudomonas - Candida interactions: An ecological role for virulence factors. Science 2002; 296: 2229-2231.

Hope, W., Morton, A., Eisen. D.P. 2002. Increase in prevalence of nosocomial non Candida albicans candidemia and the association of Candida krusei with fluconazole use. J. Hosp. Infect. 50: 56-65.

Husain, M.T., Karim, Q.N. and Tajuri, S. 1989. Analysis of infection in a burn ward. Burns 15: 299-302.

Jabra-Rizk, M.A., Baqui, A.A.M.A., Kelley, J.I., Falkler, W.A., Merz, W.G. and Meiller, T. F. 1999. Identification of Candida dubliniensis in aprospective study of patients in the United States. J. Clin. Microbiol. 37: 321-326.

Jabra-Rizk, M.A., Ferreira, S.M.S., Sabet, M., Falkler, W.A., Merz, W.G. and Meiller, T.F. 2001. Recovery of Candida dubliniensis and other yeasts from human immunodeficiency virus-associated periodontal lesions. J. Clin. Microbiol. 39: 4520-4522.

Jandourek, A., Brown, P., and Vazquez, J.A. 1999. Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis. Clin. Infect. Dis. 29: 1583-1584.

140

References

Jolly, S., Pujol, C., Schroppel, K. and Soli, D.R. 1996. Development of two species-specific fingerprinting probes for broad computer-assisted epidemiological studies of C. tropicalis. J. Clin. Microbiol. 34: 3063-3071.

Joseph-Horne, T. and Hollomon, D.W. 1997. Molecular mechanisms of azole resistance in fungi. FEMS Microbiology Letters. 149: 1141-1149.

Joshi, K.R., Solanki A, and Prakash,P. 1993. Morphological identification of Candida species on glucose agar, rice extract agar and cornmeal agar with and without Tween- 80. Indian J. Pathol. Microbiol. 36: 48-52.

Kantarcioglu, AS., and Yucel, A 2002. A flucytosine-resistant Cryptococcus neoformans (serotype D) strain isolated in turkey from cutaneous lesions. Med. Mycol. 40: 519-523.

Katiyar, S. K., and Edlind, T. D. 1998. Identification of Candida krusei multidrug resistance genes: potential role in azole resistance. ICAAC, C153, 38.

Katiyar, S.K., and Edlind, T.D. 2001. Identification and expression of multidrug resistance-related ABC transporter gene in Candida krusei. Med. Mycol. 39: 109-116.

Kelly, S.L., Lamb, D.C., Taylor, M., Corran, AJ., Baldwin, B.C., and Powderly, W.G. 1994. Resistance to amphotericin B associated with defective sterol delta 8-7 isomerase in a Cryptococcus neoformans strain from an AIDS patient. FEMS Microbiol. Lett. 122: 39-42.

Kelly, S.L., Lamb, D.C., Kelly, D.E., Manning, N.J., Loeffler, J., Hebart, H., Schumacher, U., and Einsele, H. 1997. Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol 11 ,6_ desaturation. FEBS Lett. 400: 80-82.

Kelly, S.L., Lamb, D.C., Juergen, L., Einsele, H., and Kelly, D.E. 1999a. The G464S amino acid substitution in Candida albicans sterol 14D-demethylase causes fluconazole resistance in the clinic through reduced affinity. Biochem. Biophys. Res. Commun. 262: 174-179.

Kelly, S.L., Lamb, D.C., and Kelly, D.E. 1999b. Y132H substitution in Candida albicans sterol 140 -demethylase confers fluconazole resistance by preventing binding to haem. FEMS Microbiol. Lett. 180: 171-175.

Kirkpatrick, C.H. 1984. Host factors in defense against fungal infections. Am. J. Med. 77: 1-12.

Kolaczkowski, M. and Goffeau, A 1997. Active efflux by multidrug transporters as one of the strategies to evade chemotherapy and novel practical implications of yeast pleiotropic drug resistance. Pharmacol Ther 76: 219-242.

141

References

Kolaczkowska, A, and Goffeau, A 1999. Regulation of pleiotropic drug resistance in yeast. Drug Resist. Updates 2: 403-414.

Kontoyiannis, D.P. 2000. Modulation of fluconazole sensitivity by the interaction of mitochondria and Erg3p in Saccharomyces cere visia e. J. Antimicrob. Chemother. 46: 191-197.

Kontoyiannis, D.P., Lewis, R.E., May, G.S., Osherov, N., and Rinaldi, M.G. 2002. Aspergillus nidulans is frequently resistant to amphotericin B. Mycoses 45: 406-407.

Kovacicova, G., Hanzen, J., Pisarcikova, M., Sejnova, D., Horn, J., Babela, R., Svetlansky, I., Lovaszova, M., Gogova, M., and Krcmery, V. 2001. Nosocomial fungemia due to amphotericin B-resistant Candida spp. in three pediatric patients after previous neurosurgery for brain tumors. J. Infect. Chemother. 7: 45-48.

Krishnamurthy, S., Gupta, V., Prasad, R., Panwar, S.L., and Prasad, R. 1998a. Expression of CDR1, a multidrug resistance gene of Candida albicans: In vitro transcriptional activation by heat shock, drugs and human steroid hormones. FEMS Microbiol. Lett. 160: 191-197.

Krishnamurthy, S., Chatterjee, U., Gupta, V., Prasad, R., Das, P., Snehlata, P., Hasnain, S.E., and Prasad, R. 1998b. Deletion of transmembrane domain 12 of CDR1, a multidrug transporter from Candida albicans, leads to altered drug specificity: expression of a yeast multidrug transporter in baculovirus expression system. Yeast 14: 535-550.

Kunova, Z., and Pieckova, E. 2002. Isolation of fluconazole-tolerant micromycetes onto different cultivation media. Folia Microbiol. 47: 113-117.

Lacassin, A, Damond, F., Chochillon, C., Longuet, P., Lebras, J., Vilde, J.L., Leport, C. 1996. Response to Fluconazole by 23 patients with Human Immunodeficiency Virus infection and oral candidiasis: Pharmacological and Mycological factors. Antimicrob. Agents Chemother.40: 1961-1963.

Lamb, D.C., Kelly, D.E., Schunck, W.H., Shyadehi, AZ., Akhtar, M., Lowe, D.J., Baldwin, B.C., and Kelly, S.L. 1997. The mutation T315A in Candida albicans sterol 14D-demethylase causes reduced enzyme activity and fluconazole resistance through reduced affinity. J. BioI. Chern. 272: 5682-5688.

Lamb, D.C., Maspahy, S., Kelly, D.E., Manning, N.J., Geber, A, Bennett, J.E., and Kelly, S.L. 1999. Purification, reconstitution, and inhibition of cytochrome P-450 sterol delta 22-desaturase from the pathogenic fungus Candida glabrata. Antimicrob. Agents Chemother. 43: 1725-1728.

Lamb, D.C., Kelly, D.E., White, T.C., and Kelly, S.L. 2000. The R467K amino acid substitution in Candida albicans sterol 14a-demethylase causes drug resistance through reduced affinity. Antimicrob. Agents Chemother. 44: 63-67.

142

References

Lasker, B.A., Page, L.S., Lott, T.J. and Kobayashi, G.S. 1992. Isolation, characterization, and sequencing of Candida albicans repetitive element 2. Gene 116: 51-57.

Lattif, A.A., Banerjee, U., Prasad, R., Biswas, A., Wig, N., Sharma, N., Haque, A., Gupta, N., Baquer, N.Z., Mukhopadhyay, G. Susceptibility pattern and molecular type of species-specific Candida in oropharyngeal lesions of Indian human immunodeficiency virus-positive patients. J. Clin. Microbiol. 42: 1260-1262.

Le Crom, S., Devaux, F., Marc, P., Zhang, X., Moye-Rowley, W.S., and Jacq, C. 2002. New insights into the pleiotropic resistance network from genome-wide characterization of the YRR1 transcription factor regulation. Mol. Cell. BioI. 22: 2642-2649.

Lenhart, K. 1970. Griseofulvin resistance in dermatophytes. Experientia 26: 109-110.

Lenhart, K., and Merkunova, A. 1994. Mutants of dermatophytes resistant to ketoconazole. Acta Univ. Palacki. Olomuc. Fac. Med. 137: 15-17.

Leung, A.Y., Chim, C.S., Ho, P.L., Cheng, V.C., Yuen, K.Y., Lie, A.K., Au, W.Y., Liang, R. and Kwong, Y.L. 2002. Candida tropicalis fungaemia in adult patients with haematological malignancies: clinical features and risk factors. J. Hosp. Infect. 50: 316-319.

Li, W.W., Hsiung, Y., Wong, V., Galvin, K., Zhou, Y., Shi, Y. and Lee, A.S. 1997. Suppression of grp78 core promoter element-mediated stress induction by the dpbA and dpbB (YB-1) cold shock domain proteins. Molecular and Cellular Biology. 17: 61-68.

Loffler, J., Kelly, S.L., Hebart, H., Schumacher, U., Lass-Fiori, C., and Einsele, H. 1997. Molecular analysis of cyp51 from fluconazole-resistant Candida albicans strains. FEMS Microbiol. Lett. 151: 263-268.

Lukacs, A., Korting, H.C., and Lindner, A. 1994. Successful treatment of griseofulvin-resistant tinea capitis in infants. Mycoses 37: 451-453.

MacMillan, B.G. 1981. The control of burn wound sepsis. Intensive Care Med. 7: 63-69.

Maenza, J.R., Merz, W.G., Romagnoli, M.J., Keruly, J.C., Moore, R.D. and Gallant, J.E. 1997. Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology. Clin. Infect. Dis. 24: 28-34.

Magaldi, S., Mata, S., Hartung, C., Verde, G., Deibis, L., Roldan, Y., Marcano, C. 2001. In vitro susceptibility of 137 Candida sp. Isolates from HIV positive patients to several antifungal drugs. Mycopathologia. 149: 63-68.

143

References

Makarova, N.U., Pokrowisky, V.v., Kravchnko, A.V., Serebrovskaya, L.V., James, M.J., McNeil, M.M., Lasker, B.A., Warnock, D.W. and Reiss, E. 2003. Persistence of oropharyngeal Candida albicans strain with reduced susceptibilities to fluconazole among human immunodeficiency virus-seropositive children and adults in a long term care facility. J. Clin. Microbiol. 41: 1833-1837.

Marchetti, 0., Moreillon, P., Entenza, J.M., Vouillamoz, J., Glauser, M.P., Bille, J., and Sanglard, D. 2003. Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the COR1, COR2, CaMOR1, and FLU1 genes. Antimicrob. Agents Chemother. 47: 1565-1570.

Marichal, P., Gorrens, J., Coene, M.-C., Le Jeune, L., and Vanden Bossche, H. 1995. Origin of differences in susceptibility of Candida krusei to azole antifungal agents. Mycoses 38: 111-117.

Marichal, P., Vanden Bossche, H., Odds, F.C., Nobels, G., Warnock, D.W., Timmerman, V., Van Broeckhoven, C., Fay, S., and Mose-Larsen, P. 1997. Molecular biological characterizations of an azole-resistant Candida glabrata isolate. Antimicrob. Agents Chemother. 41: 2229-2237.

Marichal, P. 1999. Mechanisms of resistance to azole antifungal compounds. Curr. Opin. Anti-infect. Investigat. Drugs 1: 318-333.

Marichal, P., Koymans, L., Willemsens, S., Bellens, D., Verhasselt, P., Luyten, W., Borgers, M., Ramaekers, F. C. S., Odds, F. C., and Vanden Bossche, H. 1999. Contributions of mutations in the cytochrome P450 14alpha-demethylase (ERG11, CYP51) to azole resistance in Candida albicans. Microbiology 145: 2701-2713.

Martin, M.v., and Dinsdale, R.C. 1982. Nystatin-resistance of Candida albicans isolates from two cases of oral candidiasis. Br. J. Oral Surg. 20: 294-298.

Mas, J., and Pina, E. 1980. Disappearance of nystatin resistance in Candida mediated by ergosterol. J. Gen. Microbiol. 117: 249-252.

Mathews, M.S., Samuel, P.R. and Suresh, M. 2001. Emergence of Candida tropicalis as the major cause of fungaemia in India. Mycoses 44: 278-280.

Mazumder, C., Basu, J., Kundu, M., and Chakrabarti, P. 1990. Changes in membrane lipids and amino acid transport in a nystatin-resistant Aspergillus niger. Can. J. Microbiol. 36: 435-437.

Mazur, P., Morin. N., Baginsky, W., el-Sherbeni, S., Clemas, M.J., Nielson, J. and Floor, F. 1995. Differential expression and function of two homologous subunits of yeast 1, 3-beta-D-glucan synthase. Molecular and Cellular Biology. 15: 5671-5681.

144

References

McCarthy, G.M. 1992. Host factors associated with HIV - related oral candidiasis. A review. Oral Surg. Oral Med. Oral Pathol. 73: 181-186.

Mc Clenny, N.B., Fei, H., Baron, E.J., Gales, AC., Houston, A, Hollis, R.J., and Pfaller, M.A 2002. Change in colony morphology of Candida lusitaniae in association with development of amphotericin B resistance. Antirnicrob. Agents Chemother. 46: 1325-1328.

Merz, W.G., and Sandford, G.R. 1979. Isolation and characterization of a polyene -resistant variant of Candida tropicalis. J. Clin. Microbiol. 9: 677-680.

Miyahara, K., Hirata, D., and Miyakawa, 1. 1996. yAP-1- and yAP-2-mediated, heat shock-induced transcriptional activation of the multidrug resistance ABC transporter genes in Saccharomyces cere visia e. Curro Genet. 29: 103-105.

Miyazaki, H., Miyazaki, Y., Geber, A, Parkinson, 1., Hitchcock, C.A, Falconer, D.J., Ward, D.J., Marsden, K., and Bennett, J.E. 1998. Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata. Antimicrob. Agents Chemother. 42: 1695-1701.

Morace, G., Sanguinetti, M., Posteraro, B., Lo Cascio, G. and Fadda, G. 1997. Identification of various medically important Candida species in clinical specimens by PCR restriction enzyme analysis. J. Clin. Microbiol. 35: 667-672.

Moran, G.P., Sanglard, D., Donnelly, S.M., Shanley, D.B., Sullivan, D.J., and Coleman, D.C. 1998. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 42: 1819-1830.

Mousa, H.A 1999. Fungal infection of burn wounds in patients with open and occlusive treatment methods. East Mediterr. Health J. 5: 333-336.

Mousa, H.A and AI-Bader, S.M. 2001. Yeast infection of burns. Mycoses 44: 147-149.

Mousa, H.A 2003. Aerobic, anaerobic and fungal burn wound infections. J. Hosp. Infect. 37: 317-323.

Moye-Rowley, W.S. 2002. Transcription factors regulating the response to oxidative stress in yeast. Antioxid. Redox Signal. 4: 123-140.

Mukhopadhyay, K., Prasad, T., Saini, P., Pucadyil, 1.J., Chattopadhyay, A and Prasad, R. 2004. Membrane Sphingolipid-Ergosterol Interactions Are Important Determinants of Multidrug Resistance in Candida albicans. Antimicrob. Agents Chemother.48: 1778-1787.

145

References

Muller, F.M., Lischewski, A, Harmsen, D. and Hacker, J. 1999 Standardized molecular typing. Mycoses 42: 69-72.

Nascimento, AM., Goldman, G.H., Park, S., Marras, S.AE., Delmas, G., Oza, U., Lolans, K., Dudley, M.N., Mann, P.A, and Perlin, D.S. 2003. Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole. Antimicrob. Agents Chemother. 47: 1719-1726.

Nes, W.R., Sekula, B.C., Nes, W.D., and Adler, J.H. 1978. The functional importance of structural features of ergosterol in yeast. J BioI Chem 255: 6218-6225.

National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeast. Approved standard M-27 A National Committee for Clinical Laboratory Standards, Wayne, Pa.

Nedret, K.A, Kocagoz, S., Erdem, F. and Gunduz, Z. 2002. Outbreak of nosocomial fungemia caused by Candida glabrata. Mycoses 45: 470-475.

Noel, T., Francois, F., Paumard, P., Chastin, C., Brethes, D., and Villard, J. 2003. Flucytosine-fluconazole cross resistance in purine-cytosine permease-deficient Candida lusitaniae clinical isolates: indirect evidence of a fluconazole uptake transporter. Antimicrob. Agents Chemother. 47: 1275-1284.

Odds, F.C. 1988. Candida and Candidosis: a review and bibliography, 2nd ed. Bailliere Tindall, London, United Kingdom.

Odds, F.C. 1993. Resistance of yeasts to azole-derivative antifungals. J. Antimicrob. Chemother. 31: 463-471.

Ogawa, A, Hashida-Okado, T., Endo, M., Tsuruo, T., Takesako, K., and Kato, I. 1998. Role of ABC transporters in aureobasidin A resistance. Antimicrob. Agents Chemother. 42: 755-761.

Onyewu, C., Blankenship, J.R., Poeta, M.D., and Heitman, J. 2003. Ergosterol Biosynthesis inhibitors become fungicigal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata and Candida krusei. Antimicrob. Agents Chemother. 47: 956-964.

Order SE, Mason AD Jr, Switzer WE and Moncrief JA Arterial vascular occlusion and devitalization of burn wounds. Ann Surg. 1965; 161 :502-8.

Orozco, AS., Higginbotham, L.M., Hitchcock, C.A, Parkinson, T., Falconer, D.J., Ibrahim, AS., Ghannoum, M.A, and Filler, S.G. 1998. Mechanism of fluconazole resistance in Candida krusei. Antimicrob. Agents Chemother. 42: 2645-2649.

Osherov, N., Kontoyiannis, D.P., Romans, A, and May, G.S. 2001. Resistance to itraconazole in Aspergillus nidulans and Aspergillus fumigatus is conferred by extra

146

References

copies of the A. nidulans P-450 14alpha-demethylase gene, pdmA. J. Antimicrob. Chemother. 48: 75-81.

Park, K.S., Kwon, J. and Choi, S.Y. 1998. Cloning, characterization and expression of the CIP2 gene induced under Cadmium stress in Candida sp. FEMS Microbiol. Lett. 162: 325-330.

Paulsen, LT., Brown, M.H., and Skurray, R.A. 1996. Proton-dependent multidrug efflux systems. Microbiol. Rev. 60: 575-608.

Perea, S., Lopez-Ribot, J.L., Kirkpatrick, W.R., McAtee, R.K., Santillan, R.A., Martinez, M., Calabrese, D., Sanglard, D., and Patterson, T.F. 2001. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 45: 2676-2684.

Perepnikhatka V., Fischer F.J., Niimi M., Baker R.A., Cannon R.D., Wang Y.K., Sherman F., and Rustchenko E. 1999. Specific chromosome alterations in fluconazole-resistant mutants of Candida albicans. J Bacterio/181: 4041-4049.

Pfaller, M. and Wenzel, R. 1992. Impact of the changing epidemiology of fungal infection in the 1990s. Eur. J. Clin. Microbiol. Infect. Dis. 11: 287-291.

Pfaller, M.A. 1994. Epidemiology and control of fungal infections. Clin. Infect. Dis. 19: S8-S13.

Pfaller, M.A. 1996. Nosocomial candidiasis: emerging species, reservoirs and modes of transmission. Clin. Infect. Dis. 2: 89-94.

Pfaller, M.A., Messer, S.A., Boyken, L., Huynh, H., Hollis, R.J., and Diekema, D.J. 2002. In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods. Antimicrob. Agents Chemother. 46: 3518-3521.

Pieckova, E., and Jesenska, Z. 1999. Occurrence of itraconazole-tolerant micromycetes in the soil and food products. Folia Microbiol. 44: 677-682.

Pinjon, E., Moran, G.P., Jackson, C.J., Kelly, S.L., Sanglard, D., Coleman, D.C., and Sullivan, D.J. 2003. Molecular mechanisms of itraconazole resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 47: 2424-2437.

Plouffe, J.F., Brown, D.G., Silva, J. Jr, Eck, T., Stricof, R.L. and Fekety, F.R. Jr. 1997. Nosocomial outbreak of Candida parapsilosis fungemia related to intravenous infusions. Arch. Intern. Med. 137: 1686-1689.

147

References

Poirriez, J., Breuillard, F., Francois, N., Fruit, J., Sendid, 8., Gross, S., and Dei-Cas, E. 2000. A case of chromomycosis treated by a combination of cryotherapy, shaving, oral 5-fluorocytosine, and oral amphotericin B. Am. J. Trop. Med. Hyg. 63: 61-63.

Poor, AH. and Cutler, J. E. 1981. Analysis of an in vivo model to study the interaction of host factors with Candida albicans. Infect. Immun. 31: 1104-1109.

Posteraro, B., Sanguinetti, M., Sanglard, D., La Sorda, M., Boccia, S., Romano, L., Morace, G., and Fadda, G. 2003. Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole. Mol. Microbiol. 47: 357-371.

Prasad, R., Worgifosse, P.D., Goffeau, A, and Balzi, E. 1995. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27: 320-329.

Prasad, R., Panwar S.L., and Krishnamurthy S. 2000. Drug Resistance Mechanisms of human Pathogenic Fungi -IN the Book by Marcel Dekker-"Fungal Pathogenesis: Principles and Clinical Applications ".

Prasad, R., Gupta, N. and Gaur, M. 2004. Molecular Basis of Antifungal Resistance. Book chapter in Pathogenic Fungi: Host Interactions and Emerging Strategies for Control ". Edited by: G. San-Bias and R. Calderone. Horizon Scientific Press.

Pruitt BA Jr, McManus AT, Kim SH and Goodwin CWo Burn wound infections: current status. World J Surg. 1998; 22: 135-45.

Pujol, C., Joly, S., Lockhart, S.R., Noel, S., Tibayrenc, M. and Soli, D.R. 1997. Parity among the Randomnly Amplified Polymorphic DNA Method, Multilocus Enzyme Electrophoresis, and Southern Blot Hybridization with moderately repetetive DNA probe Ca3 for fingerprinting Candida albicans. J. Clin. Microbiol. 35: 2348-2358.

Ramirez-Ramirez, N., Gutierrez-Corona, F., and Lopez-Romero, E. 1993. Nikkomycin-resistant mutants of Mucor rouxii: physiological and biochemical properties. Antonie van Leeuwenhoek 64: 27-33.

Redding, S.J., Smith, J., Farinacci, G., Rinaldi, M., Fothergill, A, Rhine-Chalberg, J., and Pfaller, M. 1994. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin. Infect. Dis. 18: 240-242.

Redding, S.W., Kirkpatrick, W.R., Saville, S., Coco, B.J., White, W., Fothergill, A, Rinaldi, M., Eng, T., Patterson, T.F., and Lopez-Ribot, J.L. 2003. Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiation. J. Clin. Microbiol. 41: 619-622.

148

References

Rex, J.H., Rinaldi, M.G., and Pfaller, M.A 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39: 1-8.

Rex, J.H., Pfaller, M.A, Galgiani, J.N., Bartlett, M.S., Espinel-Ingroff, A, ghannoum, M.A, Lancaster, M., Odds, F.C., Rinaldi, M.G., Walsh, T.J. and Barry, AL. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vito-in vivo correlation data for Fluconazole, Itraconazole and Candida infections. Clin. Infect. Dis. 24: 235-247.

Rex, J.H., Walsh, T.J., Sobel, J.D., Filler, S.G., Pappas, P.G., Dismukes, W.E. and Edward, J.E. 2000. Practice Guidelines for the treatment of candidiasis. Clin. Infect. Dis. 30: 662-678.

Reynolds, T.B. and Fink, R.G. 2001. Baker's yeast blooms into biofilms. Science. 291: 878-881.

Robert, F., Lebreton, F., Bougnoux, M.E., Paugam, A, Wassermann, D., Schlotterer, M., Tourte-Schaefer, C. and Dupouy-Camet, J. 1995. Use of Random Amplified Polymorphic DNA as a typing method for Candida albicans in epidemiological surveillance of a burn unit. J. Clin. Microbiol. 33: 2366-2371.

Rocha, E.M., Almeida, C.B., and Martinez-Rossi, N.M. 2002. Identification of genes involved in terbinafine resistance in Aspergillus nidulans. Lett. App. Microbiol. 35: 228-232.

Rogers, p.o., and Barker, K.S. 2002. Evaluation of differential gene expression in fluconazole-susceptible and -resistant isolates of Candida albicans by cDNA analysis. Antimicrob. Agents Chemother. 46: 3412-3417.

Rogers, P.D., and Barker, K.S. 2003. Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates. Antimicrob. Agents Chemother. 47: 1220-1227.

Rohwedder, J.J., and Archer, G. 1976. Pulmonary sporotrichosis: Treatment with miconazole. Am. Rev. Respir. Dis. 114: 403-406.

Roilides, E., Farmaki, E., Evdoridou, J., Francesconi, A, Kasai, M., Filioti, J., Tsivitanidou, M., Sofianou, D., Kremenopoulos, G. and Walsh, T.J. 2003. Candida tropicalis in a Neonatal Intensive Care Unit: Epidemiologic and Molecular Analysis of an Outbreak of infection with an Uncommon Neonatal Pathogen. J. Clin. Microbiol. 41: 735-741.

Roth-Ben, AZ., Altboum, Z., Berdicevsky, I., and Segal, E. 1998. Isolation of a petite mutant from a histidine auxotroph of Candida albicans and its characterization. Mycopathologia 141: 127-135.

149

References

Safdar, A., Van Rhee, F., Henslee-Downey, J.P., Singhal, S. and Mehta, J. 2001. Candida glabrata and Candida krusei fungemia after high-risk allogenic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. Bone Marrow Transplant 28: 873-878.

Safdar, A. and Armstrong, D. 2002. Prospective evaluation of Candida species colonization in hospitalized cancer patients: impact on short-term survival in recipients of marrow transplantation and patients with hematological malignancies. Bone Marrow Transplant 30: 931-935.

Safe, L.M., Safe, S.H., Subden, R.E., and Morris, D.C. 1977. Sterol content and polyene antibiotic resistance in isolates of Candida krusei, Candida parakrusei, and Candida tropicalis. Can. J. Microbiol. 23: 398-401.

Saier, M.H.Jr., and Reizer, J. 1991. Families and super families of transport proteins common to prokaryotes and eukaryotes. Curr. Opin. Struct. BioI. 1: 362-368.

Samaranayake, L.P., Fidel, P.L., Naglik, J.R., Sweet, S.P., Teanpaisan, R., Coogan, M.M., Blignaut, E. and Wanzala, P. 2002. Fungal infections associated with HIV infection. Oral Diseases 8: 151-160.

Sandven, V., Nilsen, K., Digranes, A., Tjade, T. And Lassen, J. 1997. Candida norvegenesis: a fluconazole resistant species. Antimicrob. Agents Chemother. 41: 1375-1376.

Sanglard, D., Kuchler, K., Ischer, F., Pagani, J.L., Monod, M., and Bille, J. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39: 2378-2386.

Sanglard, D., Ischer, F., Monod, M., and Bille, J. 1997. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: Characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143: 405-416.

Sanglard, D., Ischer, F., and Koymans, L. 1998a. Amino acid substitutions in the cytochrome P-450 lanosterol 14-a-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungals. Antimicrob. Agents Chemother. 42: 241-255.

Sanglard, D., Ischer, F., Calabrese, D., de Micheli, M., and Bille, J. 1998b. Multiple resistance mechanisms to azole antifungals in yeast clinical isolates. Drug Resist. Updates 1: 255-265.

Sanglard, D., Ischer, F., Calabrese, D., Majcherczyk, P.A., and Bille, J. 1999a. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob. Agents Chemother. 43: 2753-2765.

150

References

Sanglard, D., Ischer, F., and Bille, J. 1999b. The role of the ATP binding cassette (ABC)-transporter genes CgCDR1and CgCDR2 in the resistance of Candida glabrata to azole antifungals. ASM conference on Candida and Candidiasis C25.

Sanglard, D., Ischer, F., and Bille, J. 2001. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata. Antimicrob. Agents Chemother. 45: 1174-1183.

Schuetzer-Muehlbauer, M., Willinger, B., Krapf, G., Enzinger, S., Presterl, E., and Kuchler, K. 2003. The Candida albicans Cdr2p ATP-binding cassette (ABC) transporter confers resistance to caspofungin. Mol. Microbiol. 48: 225-235.

Semighini, C.P., Marins, M., Goldman, M.H., and Goldman, G.H. 2002. Quantitative analysis of the relative transcript levels of ABC transporter Atr genes in Aspergillus nidulans by real-time reverse transcription-PCR assay. Appl. Environ. Microbiol. 68: 1351-1357.

Seo, K., Akiyoshi, H., and Ohnishi, Y. 1999. Alteration of cell wall composition leads to amphotericin B resistance in Aspergillus flavus. Microbiol. Immunol. 43: 1017-1025.

Sheridan, R.L. and Weber, J.M. 1995. Budkevich LG, Tomkins RG. Candidemia in the pediatric patient with burns. J. Burn Care Rehabil. 16: 440-443.

Shukla, S., Saini, P., Smriti, Jha, S., Ambudkar, S.V., and Prasad, R. 2003. Functional characterization of Candida albicans ABC drug transporter Cdr1 p. Eukaryotic Cell 2: 1361-75.

Skovsgaard, T., Nielsen, D., Maare, C. and Wasserman, K. 1994. Cellular resistance to cancer chemotherapy. International Review of Cytology. 156: 77-157.

Slaven, J. W., Anderson, M. J., Sanglard, D., Dixon, G. K., Bille, J., Roberts, I. S., and Denning, D. W. 1999. Induced expression of a novel ABC transporter gene adr1 from Aspergillus fumigatus in response to itraconazole. ICAAC 36. J447- 555.

Slaven, J.W., Anderson, M.J., Sanglard, D., Dixon, G.K., Bille, J., Roberts, I.S., and Denning, D.W. 2002. Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate. Fungal Genet. BioI. 36: 199-206.

Smith, D.J. Jr. and Thomson, P.D. 1992. Changing flora in burn and trauma units: historical perspective - experience in the United States. J. Burn Care Rehabil. 13: 276-280.

Soli, D.R. 2000. The ins and outs of DNA fingerprinting the infectious fungi. Clin. Microbiol. Rev. 13: 332-370.

151

References

Spebar, M.J. and Pruitt, B.A. Jr. 1981. Candidiasis in the burned patient. J. Trauma 21: 237-239.

Stark, G.R. and Wahl, G.M. 1984. Gene amplification. Annu. Rev. Biochem. 53: 447-491.

Stephan, F., Bah, M.S., Desterke, C., Rezaiguia-Delclaux, S., Foulet, F., Duvaldestin, P. and Bretagne S. 2002. Molecular diversity and routes of colonization of Candida albicans in a surgical intensive care unit, as studied using microsatellite markers. Clin. Infect. Dis. 35: 1477-1483.

Sterling, T.R, Gasser, RA.J., and Ziegler, A. 1996. Emergence of resistance to amphotericin B during therapy for Candida glabrata infection in an immunocompetent host. Clin. Infect. Dis. 23: 187-188.

Still, J.M. Jr, Belcher. K. and Law, E.J. 1995. Management of Candida septicemia in a regional burn unit. Burns 21: 594-596.

Stolz, E. 1996. Failure of terbinafine treatment in 2 children with Tinea capitis. Ned. Tijdschr. Geneeskd.140 (36): 1833.

Sullivan, D.J., Westerneng, T.J., Haynes, K.A., Bennett, D.E. and Coleman, D.C. 1995. Candida dubliniensis sp. phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV infected individuals. Microbiology 141: 1507-1521.

Sullivan, D.J., Coleman, D.C. 2000. Molecular typing and epidemiology of Candida spp. and other important human fungal pathogens - IN the Book by Marcel Dekker-"Fungal Pathogenesis: Principles and Clinical Applications ".

Susan, E.R, Lasker, B.A., Butcher, D.S., Mc. Neil, M.M., Pruitt, R, Keyserling, H. and Jarvis, W.R 1998. Nonperinatal nosocomial transmission of Candida albicans in a neonatal intensive care unit: prospective study. J. Clin. Microbiol. 36: 1255-1259.

Talibi, D., and Raymond, M. 1999. Isolation of a putative Candida albicans transcriptional regulator involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation in Saccharomyces cerevisiae. J. Bacteriol. 181: 231-240.

Theiss, S., Agabian, N., and Kohler, G. 1999. Molecular characterization of a new ATP-dependent transporter in Candida albicans. ASM conference on Candida and Candidiasis C29.

Thornewell, S.J., Peery, R.B., and Skatrud, P.L. 1997. Cloning and characterization of CneMDR1: a Cryptococcus neoformans gene encoding a protein related to multidrug resistance proteins. Gene 201: 21-29.

152

References

Tobin, M.B., Peery, R.B., and Skatrud, P.L. 1997. Genes encoding multiple drug resistance-like proteins in Aspergillus fumigatus and Aspergillus flavus. Gene 200: 11-23.

Tumbarello, M., Bevilacqua, N., Federico, G., Morace, G., Cauda, R., and Tacconelli, E. 1996. Fluconazole resistant Candida parapsilosis fungemia in a patient with AIDS. Clin. Infect. Dis. 22: 179-180.

Vanden Bossche, H., Marichal, P., Gorrens, J., Coene, M.C., Willemsens, G., Bellens, D., Roels, I., Moereels, H., and Janssen, P.AJ. 1989. Biochemical approaches to selective antifungal activity, focus on azole antifungals. Mycoses 32: 35-52.

Vanden Bossche, H., Marichal, P., Odds, F.C., Le Jeune, L., and Coene, M.C. 1992. Characterization of an azole resistant Candida g/abrata isolate. Antimicrob. Agents Chemother. 36: 2602-2610.

Vanden Bossche, H., Marichal, P., and Odds, F.C. 1994. Molecular mechanisms of drug resistance in fungi. Trends Microbiol. 2: 393-400.

Vanden Bossche, H., Dromer, F., Improvisi, L., Lozano-Chiu, M., Rex, J.H., and Sanglard, D. 1998. Antifungal drug resistance in pathogenic fungi. Med. Mycol. 36: 119-128.

Van der Bleik, AM., Baas, F., Van der Velde-Koerts, T., Biedler, J.L., Meyers, M.B., Ozols, R.F., Hamilton, T.C., Joenje, H., and Borst, P. 1988. Genes amplified and overexpressed in human multidrug-resistant cell lines. Cancer Res. 48: 5927-5932.

Van Duin, D., Casadevall, A., and Nosanchuk, J.D. 2002. Melanization of Cryptococcus neoformans and Histoplasma capsu/atum reduces their susceptibilities to amphotericin Band caspofungin. Antimicrob. Agents Chemother. 46: 3394-4000.

Venkateswarlu, K., Denning, D.W., Manning, N.J., and Kelly, S.L. 1996. Reduced accumulation of drug in Candida krusei accounts for itraconazole resistance. Antimicrob. Agents Chemother. 40: 2443-2446.

Venkateswarlu, K., Taylor, M., Manning, N.J., Rinaldi, M.G., and Kelly, S.L. 1997. Fluconazole tolerance in clinical isolates of Cryptococcus neoformans. Antimicrob. Agents Chemother. 41: 748-751.

Vrioni, G. and Matsiota-Bernard, P. 2001. Molecular typing of Candida isolates from patients hospitalized in an intensive care unit. Journal of Infection 42:50-56.

Wada, S., Niimi, M., Niimi, K., Holmes, AR., Monk, B.C., Cannon, R.D., and Uehara, Y. 2002. Candida glabrata ATP-binding cassette transporter Cdr1 p and Pdh1 p expressed in a Saccharomyces cerevisiae stain deficient in membrane transporters

153

References

show phosphorylation dependent pumping properties. J. BioI. Chem. 277: 46809-46821.

Walsh, T.J., Petraitis, V., Petraitiene, R., Field-Ridley, A, Sutton, D., Ghannoum, M., Sein, T., Schaufele, R., Peter, J., Bacher, J., Casler, H., Armstrong, D., Espinel-Ingroft, A, Rinaldi, M.G., and Lyman, C.A 2003. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin Brit. J. Infect. Dis. 188: 305-319.

Wendler, F., Bergler, H., Prutej, K., Jungwirth, H., Zisser, G., Kuchler, K., and Hogenauer, G. 1997. Diazoborine resistance in the yeast Saccharomyces cerevisiae reveals a link between YAP1 and the pleitropic drug resistance genes POR1 and POR3. J. BioI. Chem. 272: 27091-27098.

Wheat, J., Marichal, P., Vanden Bossche, H., Le Monte, A, and Connolly, P. 1997. Hypothesis on the mechanism of resistance to fluconazole in Histoplasma capsulatum. Antimicrob. Agents Chemother. 41: 410-414.

White, T.C. 1997a. Increased mRNA levels of ERG16, CDR, and MOR1 correlate with increased azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 41: 1482-1487.

White, T.C. 1997b. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14D-demethylase in Candida albicans. Antimicrob. Agents Chemother. 41: 1488-1494.

White, T.C., Pfaller, M.A, Rinaldi, R.G., Smith, J. and Redding, S.W. 1997c. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV infected patient. Oral Dis. 3: 102-109.

White, T.C. 1997d. Antifungal drug resistance in Candida albicans. ASM News 63: 427-433.

White, T.C., Marr, K.A, and Bowden, R.A 1998. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11: 382-402.

White, T.C., Holleman, S., Dy, F., Mirels, L.F., and Stevens, D.A 2002. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob. Agents Chemother. 46: 1704-1713.

Wilkinson, C.F., Hetnarski, K., and Yellin, T.O. 1972. Imidazole derivatives-a new class of microsomal enzyme inhibitors. Biochem. Phamacol. 21: 3187-3192.

Wilkinson, C.F., Hetnarski, K., and Hicks, L.J. 1974. Substituted imidazoles as inhibitors of microsomal oxidation and insecticide synergists. Pesticide Biochem. Physiol. 4: 299-312.

154

References

Wirsching, S., Michel, S., Kohler, G. and Morschhauser, J. 2000. Activation of the multiple drug resistance gene MDR1 in Fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-Regulatory factor. 182: 400-404.

Xu, J., Boyd, C. M., Livingston, E., Meyer, W., Madden, J. F. and T. G. Mitchell. 1999. Species and Genotypic Diversities and Similarities of Pathogenic Yeasts Colonizing Women. J. Clin. Microbiol. 37:3835-3843.

Zhang, X., Cui, Z., Miyakawa, T., and Moye-Rowley, W. S. 2001. Crosstalk between transcriptional regulators of multidrug resistance in Saccharomyces cerevisiae. J. BioI. Chem. 276: 8812-8819.

155